Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Ongoing Initiated Feb 19, 2026 (8 months ago)

Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Tablet/Capsule Specifications

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35

Affected NDCs 69208-0003-15 69208-0003-25 69208-0003-35

Compare with the code on your package — it is the most precise check available.

Recalling firm
Radnostix
Origin
ID, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0401-2026 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.

Other recalls by Radnostix

All 2026 recalls

Other failed specification recalls from 2026

All failed specification recalls
Class II · Moderate risk

Pemrydi Rtu

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Ongoing Failed specification Shilpa Medicare Limited D-0765-2026
Class II · Moderate risk

Pemrydi Rtu

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Ongoing Failed specification Shilpa Medicare Limited D-0764-2026
Class II · Moderate risk

Rising

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

Ongoing Failed specification Rising Pharma Holding, Inc. NDC 64980-504-48 D-0724-2026